Parasitic Infections in HIV-Infected Patients
Summary
- Secondary prophylaxis should be administered to all patients who have completed initial therapy for toxoplasmic encephalitis (Table 4)[CDC OI; EACS]
- Preferred regimen is pyrimethamine plus sulfadiazine plus leucovorin (folinic acid)
- Prophylaxis can be discontinued if the patient’s CD4+ cell count increases to > 200 cells/mm3 with use of ART for > 6 months and HIV-1 RNA remains undetectable (Table 5)[CDC OI; EACS; Miro 2006]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content